Brand Name: LINAGLIPTIN
Generic Name: Linagliptin Tablets USP
Available Strengths:
Linagliptin Tablets 2.5mg/ 5mg
Linagliptin Tablets are an effective DPP-4 inhibitor used to manage Type 2 diabetes mellitus. The medicine works by increasing incretin hormone levels, which stimulate insulin release and decrease excess glucose production in the liver. Linagliptin offers smooth, sustained blood sugar control without causing significant hypoglycemia and can be used alone or in combination with other antidiabetic medicines. It is well-tolerated, convenient with once-daily dosing, and suitable for patients with renal impairment as no dose adjustment is usually required. Manufactured under strict pharmaceutical standards, Linagliptin Tablets ensure consistent quality, safety, and therapeutic effectiveness for long-term diabetes management.
Capabilities Offered:
Ready dossier for both strengths in CTD/ ACTD format
Third party manufacturing services
Contract Manufacturing (CMO Services)
Formulation Development Services
Regulatory & Documentation Support
Export / Licensing Services
In addition to the products listed on our website, we possess the technical capability and infrastructure to develop and manufacture customized formulations as per your specific requirements and regulatory markets.
For business inquiries, email at sales@cooperpharma.com